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Highlights 
 Solstice® PF is a viable carrier solvent alternative to HFE7100. 
 Solstice® PF is non-ozone depleting with a lower GWP, surface tension and cost. 
 Number of fingermarks detected by HFE7100 and Solstice® PF formulations was comparable 
 1,2-indanedione developed 1.2 times as many fingermarks as DFO in a pseudo-operational 
trial. 
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Abstract 
Solstice® Performance Fluid (PF), trans-1-chloro-3,3,3-trifluoropropene, is presented as an 
alternative to HFE7100, methoxy-nonafluorobutane, as a carrier solvent in a number of chemical 
formulations used for the visualisation of latent fingermarks. The supply of HFE7100 may be at risk 
due to a recent European Union regulation to control global warming. Laboratory trials using split 
depletions and a pseudo-operational trial of 1000 porous samples have shown that Solstice® PF is a 
viable alternative to HFE7100 for the chemical formulations of ninhydrin and 1,2-indanedione. Other 
preliminary trials have also indicated that Solstice® PF can be used as a carrier solvent for the zinc 
toning of marks found using ninhydrin as well as the α-naphtholflavone fixative solution for iodine 
developed marks. Results from the pseudo-operational trial demonstrate that the number of marks 
detected by ninhydrin and 1,2-indanedione formulations for each carrier solvent is comparable. 
When compared to HFE7100, advantages of Solstice® PF include a very low global warming potential 
and atmospheric lifetime in addition to a higher wetting index and lower costs. This study also 
provides a validation study that supports the potential replacement of DFO with 1,2-indanedione.  
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Introduction 
 
Due to the global warming effect contributed by fluorinated greenhouse gases, the European 
Parliament is considering a ban on some of the hydrofluorinated solvents listed in Annex II of 
Regulation (EU) No 517/2014 of 16 April 2014 [1]. Fluorinated gases listed in Annex I of the 
regulation will see a reduction year on year until 2030 whereas those listed in Annex II are currently 
only subject to reporting quantities placed on the market to the EU commission. Therefore, an 
alternative and effective replacement for HFE as the carrier solvent in a number of chemical 
formulations used in latent fingermark development needs to be investigated due to the potential 
withdrawal, partial or otherwise, of HFE products.  
 
The reaction of ninhydrin with amino acids and proteins to produce a purple colouration 
(Ruhemann’s complex) has been known for over 100 years. The carrier solvent for amino acid 
reagent formulations has changed many times since the first reported use of ninhydrin as a 
fingerprint reagent in 1954. Such changes were applied to improve the safety of the reagent (e.g. 
non-flammable ninhydrin), the performance of the reagent (addition of acetic acid to ninhydrin 
formulation) and environmental regulations (replacement of CFC-113). Oden and van Hofsten [2] 
reported one of the first instances of ninhydrin (acetone-based) for the detection of latent 
fingermarks on paper. Other studies have investigated the use of petroleum ether, 1,1,2-
trifluorotrichloroethane (CFC-113) and heptane as carrier solvents for the ninhydrin reaction [3–5]. 
The UK Home Office Centre for Applied Science and Technology (CAST) does not recommend the use 
of petroleum ether or heptane due to its flammability. In the UK, CFC-113 was the main solvent 
carrier from 1974 up to the late 1990s until it was banned under the Montreal Protocols of 1987.  
CAST embarked on a research project to find an alternative for CFC-113 formulations that was non-
flammable, non-toxic, volatile and relatively non-polar to minimise the diffusion of ink [6,7].  Ideally, 
the alternative solvent should also provide equivalent, or superior, performance in the detection of 
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latent fingermarks on porous surfaces. An early study identified Genesolv 2000 as a possible 
replacement for both ninhydrin and DFO; however, the solvent resulted in ink removal or diffusion 
[8]. CAST identified hydrochlorofluorocarbons (HCFC), hydrofluorocarbons (HFC) and 
hydrofluoroethers (HFE) as potential replacements to CFC-113. It may be assumed that the efficiency 
of the reagent is largely unaffected by the choice of carrier solvent; however, trials by CAST have 
indicated otherwise. Ninhydrin formulations based on two solvents, 2,3-dihydrodecafluoropentane 
(HFC-4310mee) and 1-methoxynonafluorobutane (HFE7100) outperformed CFC-113 formulations 
based on laboratory trials which were also confirmed by pseudo-operational trials [7,9]. Similar 
results were reported by Petruncio [10] whereby HFC-4310mee and HFE7100 provided an increased 
detection rate and reduced ink diffusion in a comparative study including petroleum ether. Around 
2009 [11], in an effort to reduce costs to police forces, CAST investigated an alternative solvent for 
ninhydrin formulations, Asahiklin AE-3000. Initial price estimates were quoted as 30% cheaper than 
HFE7100; however, further estimates from the supplier indicated that there will be little, if any, cost 
saving. A pseudo-operational comparative trial between ninhydrin formulations of HFE7100 and AE-
3000 indicated that there was no statistical difference between the effectiveness of these two 
ninhydrin formulations [11,12]. Research has also investigated analogues of ninhydrin to improve the 
detection of fingermarks by means of better contrast or fluorescence [13–17]. These have largely 
been replaced by the use of DFO and 1,2-indanedione (1,2-IND) which can be prepared using HFE 
solvents [18–20]. 
The UK Home Office Fingermark Visualisation Manual (FVM) classifies ninhydrin and DFO as ‘category 
A’ processes which are defined as “processes extensively evaluated by the Home Office and 
considered suitably effective. Standard processes for routine operational use. They must be used in 
preference to other category processes where possible” [21]. 1,2-IND is currently classified as a 
category B process that is generally less effective but has not been fully evaluated by the Home 
Office CAST. Nonetheless, in recent newsletter updates, CAST have indicated that 1,2-IND may 
replace DFO and provided an updated 1,2-IND formulation that supersedes the FVM formulation 
[22,23].  
 
This study presents a comparative pseudo-operational trial to assess the possible replacement of 
HFE7100 as the carrier solvent in the ninhydrin and 1,2-IND  formulations. The possible replacement 
solvent is Solstice® Performance Fluid (Solstice® PF), trans-1-chloro-3,3,3-trifluoropropene, 
manufactured by Honeywell Research Chemicals.  At the same time, this trial also provides a 
validation study for the potential replacement of DFO with 1,2-IND.  
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Methodology 
 
The methodology used in this study is based on recommendations for fingermark research from CAST 
[24] and the International Fingerprint Research Group [25].  
 
Laboratory  trials 
Split depletion trials using 5 donors (4 female and 1 male) were tested on white paper. Donors were 
asked not to wash their hands for at least half an hour prior to deposition. Each donor made a total 
of 4 depletion series’, each containing 8 marks in the depletion. Each series of depletion was divided 
into half and enhanced with the appropriate enhancement technique. The following comparisons 
were carried out:  ninhydrin-HFE7100 and ninhydrin-Solstice® PF; 1,2-IND-HFE7100 and 1,2-IND-
Solstice® PF; DFO-HFE and 1,2-IND-HFE7100 as well as DFO-HFE and 1,2-IND-Solstice® PF. Results 
were evaluated by putting the split series’ back to the original position and grading the developed 
fingermarks as recommended by CAST [24]. The use of Solstice® PF was also assessed and compared 
to HFE7100 in the formulations of zinc toning as well as iodine fixing. 
 
Pseudo-operational trials 
The extensive pseudo-operational trial was carried out on a variety of porous surfaces (paper, 
magazines, junk mail, newspaper and envelopes). The substrates were obtained from family, friends, 
colleagues and recycling bins. A maximum of 10 items was taken from each person. 1000 samples 
were included in this study and grouped as 250 papers, 250 envelopes, 250 junk mail/magazines and 
250 newspaper pages. In the case of newspapers and magazines, the first and last page were 
included as well as another random two pages in between. The items were treated in 10 batches of 
100 samples (25 of each substrate). Each item was split into five equal sections and labelled A 
(ninhydrin-HFE7100), B (ninhydrin-Solstice® PF), C (DFO-HFE7100/71DE), D (1,2-IND-HFE7100) and E 
(1,2-IND-Solstice® PF) [figure 1]. Sequential treatment with ninhydrin was carried out on processes C-
E. The item labeling and treatment was rotated for each sample to eliminate any bias, so, for 
example, for item no. 2 the order was B, C, D, E and A. Any marks developed with continuous ridge 
detail and an area greater than 64 mm2 were included in the count for the number of latent marks 
detected.  
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Figure 1  - Scheme of sample division for a substrate in the study. 
Formulations 
The effectiveness of the Solstice® PF solvent used for both ninhydrin and 1,2-IND processes was 
compared to the standard HFE7100 solvent. The DFO process was included in the study as a 
validation study for the possible replacement with 1,2-IND. The formulations for processes A, C and D 
were prepared according to CAST [21,23]. For the Solstice® PF processes (B and E), the same 
formulations as recommended by CAST were used by directly replacing the HFE7100 with Solstice® 
PF. To minimize evaporation, shallow troughs with a curved, corrugated bottom surface were used 
for passing through the items [21]. 
 
Ninhydrin  
A concentrated solution of ninhydrin was prepared by dissolving ninhydrin (25 g, Sigma Aldrich) in 
ethanol (225 mL, Fisher), glacial acetic acid (25 mL, Fisher) and ethyl acetate (10 mL, Fisher). A 
working solution was then prepared by measuring 52 mL of the ninhydrin concentrated solution 
together with HFE7100 (1 L, 3M Novec) or Solstice® PF (1 L, Honeywell). The articles under 
examination were drawn through the working solution in the trough and the excess liquid allowed to 
drain back before drying completely in a fume hood. The articles were then placed in a humidity 
oven (Gallenkamp FDC018) at 80 C and 65% humidity for 4 minutes. Observations of developed 
marks were checked immediately and over the next 10 days.  
 
DFO  
A DFO working solution was prepared by dissolving DFO (0.25 g, Sirchie) in methanol (30 mL, Fisher) 
and  glacial acetic acid (20 mL, Fisher) followed by the addition of HFE71DE (275 mL, 3M Novec) and 
HFE7100 (725 mL, 3M Novec). The articles under examination were drawn through the working 
solution in the trough and the excess liquid allowed to drain back before drying completely in a fume 
hood. The articles were then placed in a dry oven (Hereaus) at 100 C for 20 minutes. Fluorescence 
examination was carried out with a Quaser 2000 equipped with a green excitation source (band-pass 
filter 473-548 nm at 1% cut-on and cut-off points) and viewed with a long-pass 549 nm filter (1% cut-
on point).  
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1,2-Indanedione  
A working solution of 1,2-IND was prepared by dissolving 1,2-indanedione (0.25 g, BVDA) in ethyl 
acetate (45 mL Fisher), methanol (45 mL Fisher), glacial acetic acid (10 mL, Fisher) and zinc chloride 
stock solution (1 mL) followed by the addition of HFE7100 (1 L, 3M Novec) or Solstice® PF (1 L, 
Honeywell). The chemicals were added in the order described as the solution may become unstable 
or go cloudy. The zinc chloride stock solution was prepared by dissolving zinc chloride (0.1 g, Sigma) 
in ethyl acetate (4 mL, Fisher) and acetic acid (1 mL, Fisher). The articles under examination were 
drawn through the working solution in the trough and the excess liquid allowed to drain back before 
drying completely in a fume hood. The articles were then placed in a dry oven (Hereaus) at 100 C for 
10 minutes. Fluorescence examination was carried out with a Quaser 2000 equipped with a 
blue/green excitation source (band-pass filter 468-526 nm at 1% cut-on and cut-off points) and 
viewed with a long-pass 529 nm filter (1% cut-on point).  
 
Ninhydrin Enhancement - zinc toning 
A working solution for zinc toning was prepared by dissolving zinc chloride (1.2 g, Acros) in ethanol 
(10 mL, Fisher), 2-propanol (2 mL, Fisher) and acetic acid (2 mL, Fisher) followed by the addition of 
HFE7100 (40 mL, 3M Novec) or Solstice® PF (40 mL, Honeywell). The solution was then applied 
through an Ecospray® fine mist sprayer (nozzle diameter: 0.70 mm, flow rate: 0.45 mL/s) at a 
distance of approximately 15–20 cm. After drying, the articles were then placed in a humidity oven 
(Gallenkamp FDC018) at 80 C and 65% humidity for 4 minutes. Fluorescence examination was 
carried out with a Quaser 2000 equipped with a blue/green excitation source (band-pass filter 468-
526 nm at 1% cut-on and cut-off points) and viewed with a long-pass 529 nm filter (1% cut-on point).  
 
Iodine 
Iodine crystals were heated gently to about 50 0C in a cabinet loaded with the articles under 
examination. To prevent fading, developed marks were treated with a fixing solution. An iodine fixing 
solution was prepared by dissolving α-naphthoflavone (0.1 g, Acros) in acetic acid (5 mL, Fisher) 
followed by the addition of HFE7100 (30 mL, 3M Novec) or Solstice® PF (30 mL, Honeywell). The 
fixing solution was then applied through an Ecospray® fine mist sprayer (nozzle diameter: 0.70 mm, 
flow rate: 0.45 mL/s) at a distance of approximately 15–20 cm. 
 
Results and Discussion 
 
Solvent Properties 
A suitable alternative solvent to HFE7100 should ideally be non-flammable, non-toxic, volatile, 
environmentally friendly and relatively non-polar to minimise the diffusion of ink. Solstice® PF, 
manufactured by Honeywell, fulfills these criteria and when compared to HFE7100 has a lower 
toxicity and surface tension as well as a higher wetting index. The high wetting index indicates that 
the solvent can be absorbed easier by the substrate to reach amino acids ingrained in the pores of 
the porous substrate. Although a fluorinated solvent itself, Solstice® PF has a very low global 
warming potential (GWP) rate of 1 and atmospheric lifetime of 26 days compared to a GWP of 320 
and an atmospheric lifetime of 4.1 years for HFE7100. GWP is defined as the “climatic warming 
potential of a greenhouse gas relative to that of CO2 calculated in terms of the 100-year warming 
potential of one kilogram of a greenhouse gas relative to one kilogram of CO2 [1]. Table 1 summarises 
the solvent properties of Solstice® PF, HFE7100 and CFC-113. Solstice® PF has a boiling point of 19oC 
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but a high enthalpy of vaporisation which limits the evaporation of the solvent. According to UN 
regulations (UN3163), that classifies it as non-flammable liquefied gas, the solvent is shipped in 
pressure-rated cylinders. It also prevents loss of product by evaporation during transportation and 
storage. In addition to the environmental friendly attributes when compared to HFE7100, Solstice® 
PF has a lower cost of about a third on a single unit which increases to about a half cost-saving on 
bulk orders.  
 
 
 
Figure 2 – Solstice® PF 6kg container. 
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Table 1 – Physical Properties of three different carrier solvents. 
 Honeywell Solstice® PF Performance 
Fluid 
3M Novec HFE7100 CFC-113 
Chemical name Trans-1-chloro-3,3,3-trifluoropropene 
1233zd 
Methoxy-nonafluorobutane 1,1,2-trichloro-1,2,2-trifluoroethane 
Chemical family Hydrochlorofluoro-olefin (HCFO) 
 
Hydrofluoroether (HFE) 
 
Chlorofluorocarbon (CFC) 
Chemical formula CF3-CH=CClH C4F9OCH3 Cl2FC-CClF2 
Chemical structure 
  
 
Molecular weight 130 250 187 
Appearance Colourless Colourless Colourless 
Boiling Point (oC) 19 61 48 
Latent heat of vaporisation at bp (kJ/kg) 194 112 146  
Freezing point (oC) -107 -135 -35 
Vapour pressure at 25oC (kPa) 126  28  44 
Liquid density at 25oC (g/mL) 1.26 1.52 1.56 
Surface tension at 25oC (mN/m) 12.7 13.6 17.3 
Viscosity at 25oC (mPa.s) 0.45 0.61 0.68 
Wetting index: 1000 x density/(surface tension x viscosity) 220 183 133 
Solubility of water in solvent at 25oC (ppmv) 460 95 110 
Solubility of solvent in water (ppmv) 1900 12 170 
Flash point (oC) None None None 
Flammability range in air None None None 
Atmospheric lifetime  26 days 4.1 years 85 years 
Occupational exposure limit (ppm) 800 750 1000 
Global warming potential 1 1 320 6000 
Ozone depletion potential 2 0.00 0.00 0.80 
Cost (£)/L (inclusive of VAT) 3 
(minimum order) 
 
64.66 
(6kg drum equates to 4.76L which costs £307.80) 
Delivery charge £36 
90.93  
(5.4kg drum equates to 3.55L which costs £322.80) 
Free Delivery 
N/A 
 
Cl
F
F
F
F F
F
3
C
F CF
3
OMe
F Cl
F
F Cl
Cl
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Cost (£)/L (inclusive of VAT) 3 
(bulk order) 
43.87 
4 x 6kg drums equate to 19.05L which costs £835.20 
Delivery charge £36 
85.33 
15kg drum equates to 9.87L which costs £842.24 
Free Delivery 
N/A 
1 GWP–100 year Integration Time Horizon (ITH)         2 CFC-11 = 1.0         3 Prices as  given by Samuel Banner Chemicals and Severn Biotech for Solstice® PF and HFE7100 respectively (September 2017).  
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Laboratory Trials 
Split depletion series were done to compare the effectiveness of HFE7100 and Solstice® PF as the 
amino acid reagent carriers. Each half of the depletion series was treated with a different processing 
technique and then recombined. For both ninhydrin-HFE7100 and ninhydrin-Solstice® PF treatment 
only the first few depletions (up to the fourth) were observed (Figure 3).  The fingermarks were 
weakly visible but no obvious difference was seen between HFE7100 and Solstice® PF ninhydrin 
formulations. There was no significant quality differences between the split depletion series halves of 
fingermarks recovered with DFO and 1,2-IND-HFE (figure 4b) and 1,2-IND in both solvents (figure 4c). 
A slightly difference in fluorescence intensity was observed from the camera response but not 
visually.  
 
 
 
Figure 3 – Depletion series on paper: ninhydrin-HFE7100 (lower half), ninhydrin-Solstice® PF (upper 
half). 
 
 
Figure 4 Depletion series on paper by different donors: (a) DFO (left) and 1,2-IND-HFE (right); (b) 
DFO (left) and 1,2-IND-Solstice® PF (right); (c) 1,2-IND-HFE (left), 1,2-IND-Solstice® PF (right). 
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Pseudo-operational trial 
A pseudo-operational trial was then set-up following the successful results with split depletions 
under laboratory conditions. A pseudo-operational trial can be used to “establish whether the results 
obtained in laboratory trials are replicated on articles/surfaces typical of those that may be 
submitted to a fingerprint laboratory, or to distinguish between closely equivalent formulations that 
cannot be separated in laboratory trials” [24]. The number of fingermarks detected for each process 
is presented in tables 2 and 3. Figures 5 and 6 are the graph representatives of table 2. The results 
obtained show that both ninhydrin and 1,2-IND are comparable for the two carrier solvents tested, 
HFE7100 and Solstice® PF. There are slightly more fingermarks developed with ninhydrin-HFE7100 
(3.6% more) than with ninhydrin-Solstice® PF, whereas 1,2-IND-Solstice® PF appeared to develop the 
highest number of fingermarks which is 1.0% higher than with 1,2-IND-HFE7100 (3.8% higher for the 
Solstice® PF formulation when taking into account ninhydrin sequencing). Figure 7 represents the 
cumulative increase of fingermarks detected by batches of 100 samples. Figures 8-10 show several 
examples of enhanced latent marks with the different processes employed in this study.  
 
Before ninhydrin sequencing 
There is little difference in the number of fingermarks detected when comparing the two carrier 
solvents for ninhydrin and 1,2-IND for each substrate. 1,2-IND-HFE7100 detected considerably higher 
amount of fingermarks on envelopes whereas the opposite was true for newspapers and 1,2-IND-
Solstice® PF. A further observation is that ninhydrin-Solstice® PF developed more latent fingermarks 
on grey papers (44% more) as well as brown and grey envelopes (61% more). A second examination 
of ninhydrin developed marks after 10 days indicated an increase of approximately 11% in 
fingermark recovery. A higher number of additional marks using the ninhydrin-Solstice® PF process 
was found on paper (8%) and newspaper (21%), whereas while using the ninhydrin-HFE7100 
formulation the quantity of new marks reached 7% and 15% respectively. An equivalent number of 
new marks on magazines/leaflets (11%) was observed whereas an increase of 11% was detected with 
envelopes treated with the ninhydrin-HFE7100 formulation and 8% for the ninhydrin-Solstice® PF 
formulation. DFO (HFE formulation) was included in this study as a validation study for its possible 
replacement with 1,2-IND [23]. The results show that the total number of fingermarks developed 
with the DFO formulation is 20% lower in comparison to 1,2-IND-HFE7100 and 21% lower than 1,2-
IND-Solstice® PF formulation. The HFE7100 and Solstice® PF formulations for 1,2-IND developed 1.2 
times as many marks as DFO. In contrast, a recent CAST study [23] on 432 porous items (paper and 
cardboard) reported that 1,2-IND-HFE7100 (same formulation as this study) developed 1.6 times as 
many marks as DFO.  
 
After ninhydrin sequencing 
The DFO-ninhydrin sequence produced an increase of 27% new marks and 60% of DFO recovered 
marks were also visualised with ninhydrin treatment. Ninhydrin sequencing of 1,2-IND enhanced 
fingermarks yielded an increase of 20% and 23% for the HFE7100 and Solstice® PF formulations 
respectively. Furthermore, 63% of previously recovered 1,2-IND-HFE7100 marks and 66% of 1,2-IND-
Solstice® PF marks  were also visualised with ninhydrin treatment. DFO-ninhydrin sequencing was 
particularly effective on newspaper (61% new marks) whereas 1,2-IND-ninhydrin sequencing was 
effective for magazines (72% and 61% new marks for HFE and Solstice® PF respectively). 
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Zinc Toning 
A zinc toning solution was prepared using both HFE7100 and Solstice® PF. Successful enhancement 
was achieved for both formulations on split depletions as well as on marks recovered during the 
pseudo-operational trial (figure 11).  
 
Table 2 - Total number of fingermarks detected for each process and substrate (including sequencing). 
Surface 
A B C C 
(DFO/NIN) 
C 
(NIN New) 
D D 
(IND/NIN) 
D 
(NIN New) 
E E 
(IND/NIN) 
E 
(NIN New) 
envelopes 65 60 115 71 37 134 80 32 101 73 20 
papers 318 311 503 300 114 594 386 94 587 387 124 
magazines 45 37 47 29 14 39 24 28 51 41 31 
newspapers 65 68 33 21 20 72 37 15 108 56 24 
TOTAL 493 476 698 421 185 839 527 169 847 557 199 
 
Table 3 - Cumulative number of fingermarks detected for each process and substrate. 
 
envelopes paper magazines newspaper 
Batch A B C D E A B C D E A B C D E A B C D E 
1 16 12 34 58 40 49 39 65 80 51 0 0 1 0 1 8 6 1 4 7 
2 30 25 71 86 57 79 71 135 163 119 3 2 1 9 16 14 10 7 14 14 
3 36 29 89 100 62 96 93 193 242 199 11 5 2 21 24 15 10 9 14 18 
4 37 34 96 111 72 116 108 221 297 277 15 6 9 25 33 16 13 16 23 31 
5 43 43 115 125 84 135 127 265 355 348 34 26 36 51 71 31 33 36 44 70 
6 45 46 118 131 88 160 148 337 434 418 41 28 43 57 77 33 33 36 46 71 
7 46 47 131 136 98 187 185 417 502 507 44 36 53 57 78 40 42 39 56 95 
8 48 49 144 152 107 243 236 500 588 608 45 37 58 57 78 43 44 42 66 109 
9 52 54 145 156 109 262 255 551 637 659 45 37 61 64 80 54 58 44 74 121 
10 65 60 152 166 121 318 311 617 688 711 45 37 61 67 82 65 68 53 87 132 
 
 
 
Figure 5 - Number of detected fingermarks for each process on all substrates. 
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Figure 6 - Number of detected fingermarks for each process and substrate. 
 
 
 
 
Figure 7 – Cumulative number of fingermarks detected on all substrates for each process. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
14 
 
 
Figure 8 – Latent fingermarks enhanced with ninhydrin-HFE7100 (a,b) and ninhydrin-Solstice® PF 
(c,d) on paper (a,c) and on newspaper (b,d). 
 
 
Figure 9 – Latent fingermarks enhanced with DFO on various substrates: envelope (a); paper (b); 
magazine (c) and newspaper (d). 
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Figure 10 – Latent fingermarks enhanced with 1,2-IND-HFE7100 (a,b) and 1,2-IND-Solstice® PF (c,d) 
on paper (a,c) and on newspaper (b,d). 
 
 
 
Figure 11 – Depletion series on paper: ninhydrin-HFE7100-Zinc toning (lower half), ninhydrin-
Solstice® PF-zinc toning (upper half). 
 
 
Solvent Usage 
500 mL solutions were prepared for all formulations just prior to use for every two batches (200 
samples). During the pseudo-operational study, the age of the solution varied from one to fourteen 
days; however, ageing consistency across each batch of 100 samples was maintained. Solutions were 
stored in a refrigerator at 4oC with parafilm on the bottle caps and were allowed to reach room 
temperature prior to use. Preliminary trials showed that the Solstice® PF working solutions for 
ninhydrin and 1,2-IND were still effective after 6 months. All solutions showed good stability and no 
precipitation or phase separation was observed. The total amount of solvent used during the pseudo-
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operational trial of 1000 samples is given in table 4. For the ninhydrin and 1,2-IND formulations, an 
average of about 20% more solvent was required for Solstice® PF as compared to HFE7100 which 
may be explained by the lower boiling point of Solstice® PF. There appears to be no correlation 
between the quantity of solvent used for sample processing and weather conditions like temperature 
or humidity. The temperature and humidity in the laboratory were not controlled; however, external 
temperatures and relative humidity ranged from 11-19OC and 35-95% respectively during the trial. 
There were slight differences in solvent usage between each batch which may be due to varying 
sample size, sample wetness or porosity. The ninhydrin-HFE7100 solution became cloudy after 
processing approximately 25 samples. This may occur due to sample contaminants or ninhydrin 
precipitation caused by solvent evaporation. For the 1,2-IND-HFE7100 formulation no cloudy solution 
was noticed; however, the solution became slightly milky when the solvent was left to evaporate 
completely. DFO-HFE solution remained clear during the processing of samples. When the solution 
was left to evaporate, yellow oily droplets appeared on the surface. These droplets are formed due 
to water from the samples which is immiscible with the HFE solvent. For the ninhydrin and 1,2-IND 
Solstice® PF formulations there was no issues with cloudy solutions, oily droplets, phase separation 
or reagent precipitation. Two magazine samples were observed to release some dye during 
treatment with 1,2-IND-Solstice® PF.  
 
Due to the low boiling point of Solstice® PF, shallow troughs with a curved, corrugated bottom 
surface should be used to minimise evaporation. This is also advised for solutions prepared with HFE-
7100 [21]. To further minimise evaporation, solutions prepared with Solstice® PF could be prepared 
just prior to use, otherwise appropriately sealed bottles should be used to store solution in a 
refrigerator. The fact that Solstice® PF is shipped in pressure-rated cylinders prevents loss of product 
by evaporation during transportation and storage. 
 
Table 4 - Solvent usage for the pseudo-operational trial. 
Process 
A 
Ninhydrin 
(HFE-7100) 
B 
Ninhydrin 
(Solstice® PF) 
C 
DFO 
(HFE/7100/71DE) 
D 
1,2-IND 
(HFE-7100) 
E 
1,2-IND 
(Solstice® PF) 
Solvent usage  /mL 2150 2500 2100 1945 2480 
 
Ink Diffusion 
The common ink constituents are a mixture of dyes, resins and carrier components such as glycol-
based solvents or water. Exposure to polar solvents of these constituents may cause the ink to run 
and diffuse [26]. An assessment of the diffusion properties for the Solstice® PF and HFE formulations 
was carried out. A random selection of 14 different ink types and colours was prepared on A4 white 
paper and treated with the different formulations. For 1,2-IND, two writing implements, Staedtler 
(black ink felt-tip pen) and Apex (blue ball-point pen), showed minimal ink running when treated with 
Solstice® PF but not with HFE when observed under white light; however, under fluorescence 
examination, ink diffusion was observed for both carrier solvents (figure 12). No ink diffusion was 
observed when Solstice® PF was used on its own suggesting that the polar components (e.g. 
methanol, acetic acid), although in small quantities, in the 1,2-indanedione formulation also play a 
role in the minimal ink diffusion observed. Ink diffusion was also monitored during the pseudo-
operational trial. Figure 13 shows a split paper sample with no ink diffusion observed, the lower half 
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treated with ninhydrin-HFE7100 formulation and the upper half treated with the ninhydrin-Solstice® 
PF formulation. The results indicated that neither HFE nor Solstice® PF caused diffusion of 
handwritten or printed inks. From the 1000 samples in the pseudo operational trial, two samples 
showed slight ink diffusion.  
 
Iodine fixing solution 
An iodine fixing solution was prepared in both carrier solvents to assess their suitability to fix iodine 
treated marks on paper. Both solvents performed as expected where the fixative solution of α-
naphthoflavone provided a blue colour enhancement to provide further contrast. Figure 14 shows an 
example of a split handprint where one side was only fumed with iodine (right) and the other side 
was fumed with iodine followed by fixing with a α-naphthoflavone solution prepared with Solstice® 
PF (left).  
 
 
 
Figure 12 – A4 white paper with various inks as viewed under white light and fluorescence (blue-green 
light and 529 nm orange filter) after treatment with 1,2-IND: HFE7100 (a,b) and Solstice® PF (c,d). 
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Figure 13 – Split paper sample from the pseudo-operational trial treated with ninhydrin: HFE 
formulation (bottom) and Solstice® PF formulation (top). 
 
 
 
Figure 14 – A split handprint treated with iodine fuming with no fixing (right) and fixing with α-
naphthoflavone- Solstice® PF (left). 
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Conculsions 
 
As the EU is considering a ban on some of the hydrofluorinated solvents, including HFE7100, research 
into alternative solvents used in fingermark enhancement techniques is required. This study assessed 
Solstice® PF as a possible replacement to HFE7100 for the preparation of various chemical 
formulations used in the development of latent fingermarks. A pseudo-operational trial of 1000 
porous samples showed that the number of marks detected by ninhydrin and 1,2-IND formulations 
for both carrier solvents is comparable. Both solvents are fluorinated and non-ozone depleting; 
however, Solstice® PF has a much lower GWP and atmospheric lifetime as well as a higher wetting 
index (lower surface tension). Furthermore, Solstice® PF can have a cost saving of about 50% at 
current prices although an average of 20% more solvent was used during the pseudo-operational 
trial of 1000 samples. Ink diffusion for both solvents was comparable with minimal ink running. 
Although it is recognised that further research is required, this study shows that Solstice® PF is a 
viable substitute to HFE7100 as a carrier solvent in a number of chemical formulations used in the 
visualization of latent fingermarks.  
 
The increased detection rate and the reduction of heating time (10 vs 20 minutes) of 1,2-IND when 
compared to DFO provides support for the potential replacement of DFO with 1,2-IND as a category 
A process.  
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